MIR4530

Across TCGA pan-cancer cohorts, MIR4530 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MIR4530 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher MIR4530 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4530 expression acts as an unfavorable survival marker, although some lineages such as GBM and SKCM show a favorable association.

READ, TGCT, and BRCA are the cancer types where MIR4530 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	All	0.678	0.931	.002	48	view →
TGCT	OS	Tertile	III,IV	0.501	1.000	.014	36	view →
BRCA	OS	Tertile	IV	0.419	0.819	.011	27	view →
LGG	DFS	Tertile	All	0.647	0.791	<.001	25	view →
GBM	OS	Median	All	0.309	0.223	.006	23	view →
SKCM	OS	Tertile	II,III,IV	0.572	0.313	<.001	21	view →
KIRP	OS	Tertile	II,III,IV	0.847	0.431	.037	20	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
UVM	OS	Median	All	1.000	0.488	.008	14	view →
ESCA	DFS	Tertile	IV	0.692	0.221	.024	12	view →
SARC	OS	Quartile	All	0.936	0.802	.005	9	view →
LUSC	DFS	Tertile	II,III,IV	0.215	0.400	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

MIR4530–READ (OS)

Open the READ breakdown →